The Annual General Meeting of Lifecare ASA was convened as a hybrid meeting on
24 April 2025.
Morten Foros Krohnstad (Board chair) and Hans Hekland (Board member) were
re-elected as proposed by the Nomination Committee. No alternative candidates
were proposed.
All proposals on the agenda were adopted, cf. the notification of the Annual
General Meeting that was published on Oslo Stock Exchange on 3 April 2025. The
complete minutes of the Annual General Meeting are attached and also available
on https://lifecare.no/investor/governance.
About us
Lifecare ASA is a medical sensor company developing technology for sensing and
monitoring of various body analytes. Lifecare's main focus is to bring the
next generation of Continuous Glucose Monitoring ("CGM") systems to market.
Lifecare enables osmotic pressure as sensing principle. Lifecare's sensor
technology is referred to as "Sencell" and is suitable for identifying and
monitoring the occurrence of a wide range of analytes and molecules in the
human body and in pets.
Contacts
For further information, please contact:
Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40
Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42
This information is subject to disclosure under the Norwegian Securities
Trading Act, ยง5-12. The information was submitted for publication at
2025-04-24 17:30 CEST.